Maximum medical treatment for brain bleed pilot study
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a combination of medications to limit bleeding and control blood pressure after a brain bleed (intracerebral hemorrhage). Participation may help doctors learn the best way to reduce damage from the bleed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain bleed confirmed by a scan, not caused by an injury.
- You were enrolled within 6 hours of your first symptoms.
- You are over 18 years old (no upper age limit).
- You are not on palliative or comfort care in the emergency room.
- You do not have a large bleed (more than 60ml) or severe brain injury (GCS below 8).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether removing a certain type of brain bleed (intracerebral hemorrhage) very early, using a minimally invasive surgery approach, improves outcomes compared with standard treatment. It may help people whose bleed is large enough and who can have surgery within a strict time window.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
This trial tests a minimally invasive surgery to remove large, spontaneous brain hemorrhages soon after they occur. The goal is to see if this quick, targeted procedure can improve recovery compared with standard care.
This study tests a combination of a minimally invasive surgery to remove the brain bleed and a medication called deferoxamine (which may help reduce damage from the bleed). The goal is to see if this combination helps improve recovery after a brain hemorrhage.
Hear when a new Intra Cerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.